East Region Formulary
NHS Scotland

Formulary Decisions

Search for the outcome of decisions made by the Formulary Committee

Filter
Select filter(s)
Folic acid + 5-Fluorouracil + Oxaliplatin
FOLFOX
Routinely available
Local application
29/03/2023

Indication

Second-line combination chemotherapy regimen for patients with pancreatic cancer who have progressed after first–line gemcitabine-based chemotherapy and are of very good performance status.

Second-line combination chemotherapy regimen for patients with pancreatic cancer who have progressed after first–line gemcitabine-based chemotherapy and are of very good performance status.

Therapeutic Area

Malignant disease and immunosuppression

Status Description

Routinely available

Formulation

-

Comments

-